(CONTINUED)
In addition to HB 341, medical exemption bills are currently pending in the states of California and Pennsylvania.
On behalf of The Rabies Challenge Fund Charitable Trust, I again express our full support of HB 341 and urge the Agriculture & Resources Committee to vote that it “ought to pass.”
Sincerely,
Kris L. Christine
Founder, Co-Trustee
THE RABIES CHALLENGE FUND
http://www.RabiesChallengeFund.org
ledgespring@lincoln.midcoast.com
cc: Dr. W. Jean Dodds
Dr. Ronald Schultz
Representative James Roger Madalena
Senator Steve Fischmann
Representative Richard C. Martinez
Representative Gail Chasey
New Mexico Legislature
-------------------------------------------------------------------------------
[1] CDC's National Association of State Public Health Veterinarian's 2008 Compendium of Animal Rabies Prevention and Control
[2] American Animal Hospital Association Canine Vaccine Task Force. 2003 Canine Vaccine Guidelines, Recommendations, and Supporting Literature, and ibid. 2006 AAHA Canine Vaccine Guidelines, Revised,
[3] American Veterinary Medical Association 2007 RABIES VACCINATION PROCEDURES
[4] American Association of Feline Practitioners, Vaccine Advisory Panel Report, Journal of the American Veterinary Medical Association Vol. 229, No. 9 Nov. 1, 2006
[5] American Association of Feline Practitioners, Vaccine Advisory Panel Report, Journal of the American Veterinary Medical Association Vol. 229, No. 9 Nov. 1, 2006 p. 1412
[6] Frana, T.S. et als, Postmarketing Surveillance of Rabies Vaccines for Dogs to Evaluate Safety and Efficacy, Journal of the American Veterinary Medical Association Vol. 232, No. 7 April 1, 2008
[7] Dodds, W. Jean Vaccination Protocols for Dogs Predisposed to Vaccine Reactions, The Journal of the American Animal Hospital Association, May/June 2001, Vol. 37, pp. 211-214
[8] Duval D., Giger U.Vaccine-Associated Immune-Mediated Hemolytic Anemia in the Dog, Journal of Veterinary Internal Medicine 1996; 10:290-295
[9] American Veterinary Medical Association (AVMA) Executive Board, April 2001, Principles of Vaccination, Journal of the American Veterinary Medical Association, Volume 219, No. 5, September 1, 2001.
[10] Vascelleri, M. Fibrosarcomas at Presumed Sites of Injection in Dogs: Characteristics and Comparison with Non-vaccination Site Fibrosarcomas and Feline Post-vaccinal Fibrosarcomas; Journal of Veterinary Medicine, Series A August 2003, vol. 50, no. 6, pp. 286-291.
[11] IARC Monographs on the Evaluation of Carcinogenic Risks to Humans: Volume 74, World Health Organization, International Agency for Research on Cancer, Feb. 23-Mar. 2, 1999, p. 24, 305, 310.
[12] Vascelleri, M. Fibrosarcomas at Presumed Sites of Injection in Dogs: Characteristics and Comparison with Non-vaccination Site Fibrosarcomas and Feline Post-vaccinal Fibrosarcomas; Journal of Veterinary Medicine, Series A August 2003, vol. 50, no. 6, pp. 286-291.
[13] American Animal Hospital Association Canine Vaccine Task Force. 2003 Canine Vaccine Guidelines, Recommendations, and Supporting Literature, 28pp. and ibid. 2006 AAHA Canine Vaccine Guidelines, Revised, 28 pp.